drugset / Trial / NCT00919555
Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of the study is to determine the safety and the efficacy of Tretinoin and Pioglitazone HCL in patients with ALS who are currently on Riluzole.
Timeline
- Start
- 2008-06
- Primary completion
- 2009-11
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pioglitazone | Small molecule | 30 mg | Oral |
| Comparator | Tretinoin | Small molecule | 10 mg | Oral |